. home.aspx



Apixio Launches AI-Powered Solution to Advance Personalized Medicine

September 10, 2019 / Fred Pennic

Apixio Inc., an AI healthcare analytics company, today announced Quality Identifier, a new solution that allows health plans and providers to unlock critical patient insights for better quality measurement and care delivery. Quality Identifier is delivered as a secure, web-based application for in-house quality measurement teams. Quality Identifier leverages Apixio’s proprietary AI algorithms to surface insights from over 10 million patient charts, and analyze clinical data for relevant quality measures and compliance indicators to streamline and accelerate the abstraction process. These facts are presented in an application where abstractors can confirm whether predicted facts demonstrate compliance with relevant measures, significantly reducing the amount of time needed to gather clinical evidence for quality reporting. The result? Much faster chart reviews, more accurate fact-finding, and better progress tracking toward compliance benchmarks.